Cancer center partners with national oncologist network

Mark Campbell. Courtesy Cancer and Hematology Centers of Western Michigan

Cancer and Hematology Centers of Western Michigan recently entered a partnership with Nashville-based OneOncology. 

Cancer and Hematology Centers of Western Michigan (CHCWM) and OneOncology, a national platform for independent oncology practices, said last week they will be partnering to bring comprehensive oncology services to West Michigan. 

This partnership will bring CHCWM analytics, clinical technology and national connections to help the center expand its services in cancer care, including an expansion of CHCWM’s chimeric antigen receptor T cell (CAR-T) therapies and theranostics.

“Affiliating with OneOncology benefits our patients and our practice partners by providing resources to expand access to innovative treatment options for patients in West Michigan,” said Dr. Mark Campbell, president, CHCWM. 

“By aligning with other leading oncology practices, our participation in OneOncology brings the technology and data that will place CHCWM at the forefront of value-based contracting arrangements with employers and payers — a must to provide patient-centric, high-quality cancer care in our communities.” 

CHCWM has 25 medical oncologists and 55 advanced practice providers caring for patients at four main sites in Grand Rapids, Holland and Muskegon. The practice is a participant in Medicare’s Oncology Care Model and has a phase I research program, START-Midwest, with 60 open phase I trials enrolling approximately 190 patients last year. 

START-Midwest is one of the largest phase I units in the Midwest. CHCWM also boasts phase II and phase III research programs. 

“Having a practice as prestigious and innovative as the Cancer & Hematology Centers of Western Michigan further strengthens our partnership, which benefits all our practices,” said Dr. Jeff Patton, MD, CEO, OneOncology. “The Western Michigan physicians bring their patients the best in cancer care services, including clinical trials and innovative therapies. We look forward to working with them to expand their service lines and ensure patients in western Michigan have access to cutting-edge cancer care close to home.” 

Facebook Comments